Journey Medical (DERM) Gross Profit: 2020-2025
Historic Gross Profit for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $11.9 million.
- Journey Medical's Gross Profit rose 16.91% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year decrease of 0.22%. This contributed to the annual value of $35.3 million for FY2024, which is 37.37% down from last year.
- Latest data reveals that Journey Medical reported Gross Profit of $11.9 million as of Q3 2025, which was up 17.93% from $10.1 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Gross Profit registered a high of $28.1 million during Q3 2023, and its lowest value of $5.8 million during Q1 2023.
- Over the past 3 years, Journey Medical's median Gross Profit value was $9.4 million (recorded in 2023), while the average stood at $11.1 million.
- As far as peak fluctuations go, Journey Medical's Gross Profit spiked by 216.02% in 2023, and later crashed by 63.86% in 2024.
- Quarterly analysis of 5 years shows Journey Medical's Gross Profit stood at $8.0 million in 2021, then grew by 3.20% to $8.2 million in 2022, then soared by 57.72% to $13.0 million in 2023, then slumped by 31.28% to $8.9 million in 2024, then climbed by 16.91% to $11.9 million in 2025.
- Its last three reported values are $11.9 million in Q3 2025, $10.1 million for Q2 2025, and $8.3 million during Q1 2025.